Other Consolidated Financial Statement Detail (Tables)

3 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Other income (expense), net

	For the Three Months Ended March 31,
(In millions)	2013			2012
Interest income	$	4.3		$	6.5
Interest expense	(11.5		)	(7.4		)
Impairments of investments	(0.3		)	(0.5		)
Gain (loss) on investments, net	4.4			11.8
Foreign exchange gains (losses), net	(2.6		)	1.4
Other, net	(8.8		)	3.3
Total other income (expense), net	$	(14.5	)	$	15.1

Accrued Expenses and Other

(In millions)	As of March 31, 2013		As of December 31, 2012
Revenue-related rebates	$	204.0	$	191.0
Deferred revenue	157.1		148.0
Employee compensation and benefits	134.5		248.5
Collaboration expenses	56.7		37.4
Clinical development expenses	47.9		51.6
Royalties and licensing fees	42.8		45.2
Current portion of contingent consideration obligations	21.7		22.4
Other	220.4		235.8
Total accrued expenses and other	$	885.1	$	979.9